Home

Détecter Des séries chronologiques Dépasser post vaccination pfizer Réunion paquet Transformateur

Frontiers | Trajectory of IgG to SARS-CoV-2 After Vaccination With BNT162b2  or mRNA-1273 in an Employee Cohort and Comparison With Natural Infection
Frontiers | Trajectory of IgG to SARS-CoV-2 After Vaccination With BNT162b2 or mRNA-1273 in an Employee Cohort and Comparison With Natural Infection

Spike-antibody waning after second dose of BNT162b2 or ChAdOx1 - The Lancet
Spike-antibody waning after second dose of BNT162b2 or ChAdOx1 - The Lancet

Updated Toolkit: Children and COVID-19 Vaccination - Public Health  Communication Collaborative
Updated Toolkit: Children and COVID-19 Vaccination - Public Health Communication Collaborative

Protection against SARS-CoV-2 after Covid-19 Vaccination and Previous  Infection | NEJM
Protection against SARS-CoV-2 after Covid-19 Vaccination and Previous Infection | NEJM

Biomedicines | Free Full-Text | Vaccine mRNA Can Be Detected in Blood at 15  Days Post-Vaccination
Biomedicines | Free Full-Text | Vaccine mRNA Can Be Detected in Blood at 15 Days Post-Vaccination

COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses |  Nature
COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses | Nature

Initial report of decreased SARS-CoV-2 viral load after inoculation with  the BNT162b2 vaccine | Nature Medicine
Initial report of decreased SARS-CoV-2 viral load after inoculation with the BNT162b2 vaccine | Nature Medicine

Myocarditis after BNT162b2 Vaccination in Israeli Adolescents | NEJM
Myocarditis after BNT162b2 Vaccination in Israeli Adolescents | NEJM

What happens after you're vaccinated for COVID-19 - ABC News
What happens after you're vaccinated for COVID-19 - ABC News

Covid vaccine side effects: What it's like in Pfizer, Moderna trials
Covid vaccine side effects: What it's like in Pfizer, Moderna trials

COVID-19 Vaccines Advice
COVID-19 Vaccines Advice

Frontiers | Extension and Severity of Self-Reported Side Effects of Seven  COVID-19 Vaccines in Mexican Population
Frontiers | Extension and Severity of Self-Reported Side Effects of Seven COVID-19 Vaccines in Mexican Population

Age-dependent immune response to the Biontech/Pfizer BNT162b2 COVID-19  vaccination | medRxiv
Age-dependent immune response to the Biontech/Pfizer BNT162b2 COVID-19 vaccination | medRxiv

COVID-19 Vaccines Advice
COVID-19 Vaccines Advice

How the Pfizer-BioNTech Covid-19 Vaccine Works - The New York Times
How the Pfizer-BioNTech Covid-19 Vaccine Works - The New York Times

Cardiac Complications After SARS-CoV-2 Infection and mRNA COVID-19  Vaccination — PCORnet, United States, January 2021–January 2022 | MMWR
Cardiac Complications After SARS-CoV-2 Infection and mRNA COVID-19 Vaccination — PCORnet, United States, January 2021–January 2022 | MMWR

Risk of thrombocytopenia and thromboembolism after covid-19 vaccination and  SARS-CoV-2 positive testing: self-controlled case series study | The BMJ
Risk of thrombocytopenia and thromboembolism after covid-19 vaccination and SARS-CoV-2 positive testing: self-controlled case series study | The BMJ

Interim Estimates of Vaccine Effectiveness of BNT162b2 and mRNA-1273  COVID-19 Vaccines in Preventing SARS-CoV-2 Infection Among Health Care  Personnel, First Responders, and Other Essential and Frontline Workers —  Eight U.S. Locations, December
Interim Estimates of Vaccine Effectiveness of BNT162b2 and mRNA-1273 COVID-19 Vaccines in Preventing SARS-CoV-2 Infection Among Health Care Personnel, First Responders, and Other Essential and Frontline Workers — Eight U.S. Locations, December

Effectiveness of mRNA BNT162b2 COVID-19 vaccine up to 6 months in a large  integrated health system in the USA: a retrospective cohort study - The  Lancet
Effectiveness of mRNA BNT162b2 COVID-19 vaccine up to 6 months in a large integrated health system in the USA: a retrospective cohort study - The Lancet

Cardiac Complications After SARS-CoV-2 Infection and mRNA COVID-19  Vaccination — PCORnet, United States, January 2021–January 2022 | MMWR
Cardiac Complications After SARS-CoV-2 Infection and mRNA COVID-19 Vaccination — PCORnet, United States, January 2021–January 2022 | MMWR

Antibody Responses in Seropositive Persons after a Single Dose of  SARS-CoV-2 mRNA Vaccine | NEJM
Antibody Responses in Seropositive Persons after a Single Dose of SARS-CoV-2 mRNA Vaccine | NEJM